These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10001 related articles for article (PubMed ID: 12727113)

  • 1. Induction of specific antitumor immunity in the mouse with the electrofusion product of tumor cells and dendritic cells.
    Siders WM; Vergilis KL; Johnson C; Shields J; Kaplan JM
    Mol Ther; 2003 Apr; 7(4):498-505. PubMed ID: 12727113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application.
    Trevor KT; Cover C; Ruiz YW; Akporiaye ET; Hersh EM; Landais D; Taylor RR; King AD; Walters RE
    Cancer Immunol Immunother; 2004 Aug; 53(8):705-14. PubMed ID: 15048588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma.
    Yasuda T; Kamigaki T; Kawasaki K; Nakamura T; Yamamoto M; Kanemitsu K; Takase S; Kuroda D; Kim Y; Ajiki T; Kuroda Y
    Cancer Immunol Immunother; 2007 Jul; 56(7):1025-36. PubMed ID: 17131118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2K(b)-restricted T cell epitope.
    Park JS; Kim HS; Park MY; Kim CH; Chung YJ; Hong YK; Kim TG
    Cancer Immunol Immunother; 2010 May; 59(5):747-57. PubMed ID: 19936747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors.
    Rakhmilevich AL; Buhtoiarov IN; Malkovsky M; Sondel PM
    Cancer Immunol Immunother; 2008 Aug; 57(8):1151-60. PubMed ID: 18214476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to the electrofusion process can increase the immunogenicity of human cells.
    Hock BD; Roberts G; McKenzie JL; Gokhale P; Salm N; McLellan AD; Patton NW; Roake JA
    Cancer Immunol Immunother; 2005 Sep; 54(9):880-90. PubMed ID: 15926080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.
    Brown MC; Holl EK; Boczkowski D; Dobrikova E; Mosaheb M; Chandramohan V; Bigner DD; Gromeier M; Nair SK
    Sci Transl Med; 2017 Sep; 9(408):. PubMed ID: 28931654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo.
    Mushiake H; Tsunoda T; Nukatsuka M; Shimao K; Fukushima M; Tahara H
    Cancer Immunol Immunother; 2005 Feb; 54(2):120-8. PubMed ID: 15592717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor associated antigens combined with carbon dots for inducing durable antitumor immunity.
    Liu H; Zhang T; Zheng M; Xie Z
    J Colloid Interface Sci; 2024 Nov; 673():594-606. PubMed ID: 38897061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism study on the influences of buffer osmotic pressure on microfluidic chip-based cell electrofusion.
    Xu M; Zhang X; Bai Y; Wang X; Yang J; Hu N
    APL Bioeng; 2024 Jun; 8(2):026103. PubMed ID: 38638144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines.
    Kirkin AF; Petersen TR; Olsen AC; Li L; thor Straten P; Zeuthen J
    Cancer Immunol Immunother; 1995 Aug; 41(2):71-81. PubMed ID: 7656272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrastructural studies of the effect of x-rays and quinacrine (Atebrin) or chloroquine (Resochin)--alone or in combination--on Harding-Passey melanoma cells in monolayer culture].
    Pfab R; Schachtschabel DO; Kern HF
    Strahlentherapie; 1985 Nov; 161(11):711-8. PubMed ID: 4071571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current application of sentinel lymph node lymphoscintigraphy to detect various cancer metastases.
    Hubalewska-Dydejczyk A; Sowa-Staszczak A; Huszno B
    Hell J Nucl Med; 2006; 9(1):5-9. PubMed ID: 16617387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy applied to melanoma].
    Dreno B
    Ann Dermatol Venereol; 1995; 122(4):235-40. PubMed ID: 8526418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulation of the cobra cytotoxin P4 in liposomes.
    Chaim-Matyas A; Borkow G; Ovadia M
    Biotechnol Appl Biochem; 1993 Feb; 17(1):31-6. PubMed ID: 8439402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of glycosylated human interleukin-1alpha, neoglyco IL-1alpha, by coupling with D-galactose monosaccharide: biological activities in vitro.
    Nabeshima S; Chiba T; Takei Y; Watanabe S; Okuyama H; Onozaki K
    Glycoconj J; 1998 Jan; 15(1):69-74. PubMed ID: 9530958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trypanosoma cruzi infection decreases malignant melanoma development and increases survival in C57BL/6 mice].
    Alejandra Morillo D; Elena González B; Sulbarán Larrarte AJ; Ibarra A; Alvarez C; Victoria Colmenares M; Bonfante-Cabarcas RA
    Invest Clin; 2014 Sep; 55(3):227-37. PubMed ID: 25272522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cycle reset in a melanoma cell line caused by cooling.
    Dewey DL
    Cell Tissue Kinet; 1987 Nov; 20(6):603-9. PubMed ID: 3502929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interleukin-2 and adoptive immunotherapy: their biological aspects and clinical application in oncology].
    Barón Saura JM; Pizarro Redondo A; Berrocal Jaime A; González Barón M
    Rev Clin Esp; 1991 May; 188(9):468-72. PubMed ID: 1896596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo.
    Prakash J; Bansal R; Post E; de Jager-Krikken A; Lub-de Hooge MN; Poelstra K
    Neoplasia; 2009 Dec; 11(12):1348-58. PubMed ID: 20019843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 501.